The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Collaboration streamlines patient access to oncology clinical trials
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
